These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 20172128)

  • 21. Mechanisms of cardiac preconditioning: ten years after the discovery of ischemic preconditioning.
    Meldrum DR
    J Surg Res; 1997 Nov; 73(1):1-13. PubMed ID: 9441786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat.
    Sivarajah A; McDonald MC; Thiemermann C
    Shock; 2006 Aug; 26(2):154-61. PubMed ID: 16878023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monophosphoryl lipid A induces delayed preconditioning against cardiac ischemia-reperfusion injury.
    Elliott GT
    J Mol Cell Cardiol; 1998 Jan; 30(1):3-17. PubMed ID: 9500877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardial protection by ischemic preconditioning and delta-opioid receptor activation in the isolated working rat heart.
    Karck M; Tanaka S; Bolling SF; Simon A; Su TP; Oeltgen PR; Haverich A
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):986-92. PubMed ID: 11689805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ischemic preconditioning prevents reperfusion heart injury in cardiac hypertrophy by activation of mitochondrial KATP channels.
    Rajesh KG; Sasaguri S; Suzuki R; Xing Y; Maeda H
    Int J Cardiol; 2004 Jul; 96(1):41-9. PubMed ID: 15203260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postconditioning--A new link in nature's armor against myocardial ischemia-reperfusion injury.
    Vinten-Johansen J; Zhao ZQ; Zatta AJ; Kin H; Halkos ME; Kerendi F
    Basic Res Cardiol; 2005 Jul; 100(4):295-310. PubMed ID: 15793629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrillatory arrest technique: is it worth tasting the old wine in new bottle?
    Mishra PK
    Eur J Cardiothorac Surg; 2006 May; 29(5):860; author reply 861. PubMed ID: 16520049
    [No Abstract]   [Full Text] [Related]  

  • 28. Drugs mediating myocardial protection.
    De Hert SG; Preckel B; Hollmann MW; Schlack WS
    Eur J Anaesthesiol; 2009 Dec; 26(12):985-95. PubMed ID: 19644380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Remote ischemic preconditioning].
    Maslov LN; Kolar F; Krieg T
    Usp Fiziol Nauk; 2009; 40(4):64-78. PubMed ID: 19886189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Protective effects of ischemic preconditioning on myocardium during patients undergoing heart valve replacement surgery].
    Li G; Chen S; Lu E
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(5):478-80. PubMed ID: 12080691
    [No Abstract]   [Full Text] [Related]  

  • 31. Carbohydrates and purines in underperfused hearts, protected by ischemic preconditioning.
    de Jonge R; Bradamante S; Speleman L; Willem de Jong J
    J Mol Cell Cardiol; 1998 Mar; 30(3):699-708. PubMed ID: 9515044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ischemia and reperfusion injury of the myocardium.
    Bidstrup BP; Endara SA; Boldery JO
    Heart Surg Forum; 2001; 4 Suppl 1():S40-2. PubMed ID: 11178307
    [No Abstract]   [Full Text] [Related]  

  • 33. Reperfusion injury, microvascular dysfunction, and cardioprotection: the "dark side" of reperfusion.
    Prasad A; Stone GW; Holmes DR; Gersh B
    Circulation; 2009 Nov; 120(21):2105-12. PubMed ID: 19933949
    [No Abstract]   [Full Text] [Related]  

  • 34. Myocardial protection in reperfusion with postconditioning.
    Vinten-Johansen J; Zhao ZQ; Jiang R; Zatta AJ
    Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):1035-45. PubMed ID: 16292995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heart protection by ischemic preconditioning: a novel pathway initiated by iron and mediated by ferritin.
    Chevion M; Leibowitz S; Aye NN; Novogrodsky O; Singer A; Avizemer O; Bulvik B; Konijn AM; Berenshtein E
    J Mol Cell Cardiol; 2008 Dec; 45(6):839-45. PubMed ID: 18817783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathophysiology of myocardial infarction: protection by ischemic pre- and postconditioning.
    Skyschally A; Schulz R; Heusch G
    Herz; 2008 Mar; 33(2):88-100. PubMed ID: 18344027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Moving preconditioning from bench to bedside.
    Kloner RA
    J Am Coll Cardiol; 2006 Jul; 48(1):215-6. PubMed ID: 16814670
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cardiological options for acute protection of the reperfused myocardium].
    Breuckmann F; Heusch G; Erbel R; Philipp S
    Dtsch Med Wochenschr; 2008 Mar; 133(12):591-4. PubMed ID: 18335391
    [No Abstract]   [Full Text] [Related]  

  • 39. [Mechanism of cardioprotection induced by noninvasive limb ischemic preconditioning].
    Wang NF; Xu J; Xia Q; Gao Q; Shi XX; Zhou ZL; Wang LL; Tong GX; Li H; Li PZ; Zhang X; Ling F; Pan H; Yang JM
    Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(28):1999-2002. PubMed ID: 19950578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
    du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
    Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.